[1]
M. Afshar, “Advances in Type 2 Diabetes Management: A Rapid Review of SGLT2 Inhibitors and GLP-1 Receptor Agonists : SGLT2 Inhibitors vs GLP-1 Agonists in Treatment of DM”, Chron Dis J, vol. 14, no. 2, pp. 82–93, May 2026.